04.03 Neuro

04.03 Neuro [PDF link]: Parkinson’s disease – Levodopa (+ adverse effects of dopamine), Dopamine agonists, including ropinirole, cabergoline, bromocriptine, MAO-B inhibitors, eg selegiline, COMT inhibitors, eg entacapone, Antimuscarinics, eg procyclidine. Parkinson plus syndrome – Progressive supra nuclear palsy (PSP), Corticobasal degeneration (CBD), Multiple system atrophy (MSA). Motor neurone disease (MND) – Amyotrophic lateral sclerosis (ALS). Huntington disease.

Previous
Previous

04.04 Neuro

Next
Next

04.02 Neuro